News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innova Biosciences Achieves InnovaCoat® Key Scale-Up Target


11/13/2013 9:17:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

November 13, 2013 -- Innova Biosciences, the inventor of high quality, easy to use bioconjugation kits, is pleased to announce it has reached yet another significant milestone of its programme funded by the UK’s innovation agency, the Technology Strategy Board, by meeting a key scale-up target for the production of its unique InnovaCoat® gold nanoparticle conjugation reagents.

Traditional passive methods for conjugating antibodies to gold nanoparticles require extensive optimisation, and often result in difficulties such as poor stability and aggregation. The InnovaCoat® technology developed by Innova Biosciences resolves these issues by enabling extremely stable covalent conjugates to be formed in a streamlined kit format. The resulting conjugates can be used in a wide range of applications, including in vitro diagnostic assays such as lateral flow devices. In reaching this key milestone, Innova Biosciences has confirmed its ability to support companies using high volumes of gold nanoparticles in their manufacturing processes.

Commenting on this latest success Dr Nick Gee, CEO of Innova Biosciences, said: “We are very pleased to have reached this target, which is a great testament to the scalability of our technologies, and underlines our commitment to supporting the needs of our customers in the IVD sector”.

About Innova Biosciences Limited

Innova Biosciences is a growing, dynamic, ISO 9001:2008 business based in Cambridge, UK. At the core of Innova's business are the Lightning-Link®, InnovaCoat® and Thunder-Link® technologies, which simplify the process of bioconjugation. The expanding portfolio is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. For more information, please see www.innovabiosciences.com.

About the Technology Strategy Board

The Technology Strategy Board is the UK’s innovation agency. Its goal is to accelerate economic growth by stimulating and supporting business-led innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

Managed by the Technology Strategy Board, the Smart scheme offers funding to small and medium-sized enterprises (SMEs) to engage in R&D projects in the strategically important areas of science, engineering and technology, from which successful new products, processes and services could emerge. www.innovateuk.org/deliveringinnovation/smart.ashx

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES